Filing Flows › Companies › Diversified Healthcare Trust › Timeline
Diversified Healthcare Trust stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+58.6% to $7.02
Diversified Healthcare Trust (DHC) stock rose 59% over the last 252 sessions, to $7.02. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside), and the company filed 1 material 8-K. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 2, 2026 | Earnings | Earnings: missed the EPS estimate by -1.4% | −0.5% (0.0% vs SPY) | −10.3% (−7.5% vs SPY) | — |
| Aug 3, 2026 | Earnings | Earnings: beat the EPS estimate by 36.5% | −1.0% (−2.4% vs SPY) | −0.9% (−4.4% vs SPY) | −16.2% (−18.8% vs SPY) |
| May 4, 2026 | Earnings | Earnings: beat the EPS estimate by 15.8% | −1.0% (−0.7% vs SPY) | +7.5% (+5.2% vs SPY) | +8.1% (+2.8% vs SPY) |
| Feb 23, 2026 | Earnings | Earnings: beat the EPS estimate by 65.1% | −1.4% (−0.4% vs SPY) | +8.0% (+8.5% vs SPY) | +7.1% (+11.9% vs SPY) |
| Jan 5, 2026 | 8-K | Termination of a material agreement | +3.9% (+3.3% vs SPY) | +8.1% (+6.5% vs SPY) | +16.8% (+15.9% vs SPY) |
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.02 Termination of a material agreement | 2,368 | 0.0% | 51% | +1.1% | ±1.5% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Diversified Healthcare Trust: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.